1. Home
  2. IMMX vs SELX Comparison

IMMX vs SELX Comparison

Compare IMMX & SELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMX
  • SELX
  • Stock Information
  • Founded
  • IMMX 2014
  • SELX 2021
  • Country
  • IMMX United States
  • SELX Taiwan
  • Employees
  • IMMX N/A
  • SELX N/A
  • Industry
  • IMMX Medicinal Chemicals and Botanical Products
  • SELX
  • Sector
  • IMMX Health Care
  • SELX
  • Exchange
  • IMMX Nasdaq
  • SELX Nasdaq
  • Market Cap
  • IMMX 61.1M
  • SELX 52.0M
  • IPO Year
  • IMMX 2021
  • SELX N/A
  • Fundamental
  • Price
  • IMMX $2.19
  • SELX $1.30
  • Analyst Decision
  • IMMX Strong Buy
  • SELX
  • Analyst Count
  • IMMX 1
  • SELX 0
  • Target Price
  • IMMX $7.00
  • SELX N/A
  • AVG Volume (30 Days)
  • IMMX 261.4K
  • SELX 4.6K
  • Earning Date
  • IMMX 08-11-2025
  • SELX 01-01-0001
  • Dividend Yield
  • IMMX N/A
  • SELX N/A
  • EPS Growth
  • IMMX N/A
  • SELX N/A
  • EPS
  • IMMX N/A
  • SELX N/A
  • Revenue
  • IMMX N/A
  • SELX $1,040,571.00
  • Revenue This Year
  • IMMX N/A
  • SELX N/A
  • Revenue Next Year
  • IMMX N/A
  • SELX N/A
  • P/E Ratio
  • IMMX N/A
  • SELX N/A
  • Revenue Growth
  • IMMX N/A
  • SELX N/A
  • 52 Week Low
  • IMMX $1.26
  • SELX $1.00
  • 52 Week High
  • IMMX $3.00
  • SELX $2.07
  • Technical
  • Relative Strength Index (RSI)
  • IMMX 45.97
  • SELX 44.99
  • Support Level
  • IMMX $2.16
  • SELX $1.25
  • Resistance Level
  • IMMX $2.31
  • SELX $1.47
  • Average True Range (ATR)
  • IMMX 0.17
  • SELX 0.10
  • MACD
  • IMMX -0.04
  • SELX 0.00
  • Stochastic Oscillator
  • IMMX 11.14
  • SELX 30.77

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

Share on Social Networks: